ARUP Transfusion Medicine has partnered with machine-learning experts at the U of U to develop and validate a method that can predict the need for transfusion during cardiothoracic surgery.
ARUP’s Employee Advisory Council, pictured here with CEO Andy Theurer and Santa, lead the employee charitable giving program. In 2021, ARUP raised a record $82K for nonprofits that work to cure cancer, improve community health, provide STEM education, prevent suicide, and support those affected by suicide.
Whatever you call it—altruism, generosity, or simply paying it forward—the act of serving and giving to others is a tenant central to ARUP that goes well beyond the work performed in our labs.
ARUP Consult, a free source of laboratory testing information for clinicians, released several updated resources in December.
ARUP Consult®, a free source of expert guidance in laboratory testing, has released updated resources on testing for celiac disease and trace element deficiency and toxicity.
On December 10, 2021, a Common Vulnerability and Exposure (CVE) alert was issued from NIST related to Apache Log4j, CVE-2021-44228.
Tucked inside the bill that President Biden signed to raise the national debt ceiling was a holiday gift for clinical laboratories and Medicare patients.
ARUP Consult, a free source with laboratory testing information for clinicians, released several updated resources in November.
ARUP Consult® has released updated resources on Hereditary Thrombophilia, Group B Streptococcal Disease, and Paraneoplastic Neurologic Syndromes (PNSs).
ARUP Laboratories has successfully completed the second surveillance assessment of its College of American Pathologists (CAP) International Organization for Standardization (ISO) 15189 accreditation.
ARUP Consult, a free source of lab test information for clinicians, released several new and updated resources in the month of October.
ARUP Consult released new and updated resources on genetic cardiovascular disease, the effects of common anticoagulants on coagulation testing, laboratory testing for primary sclerosing cholangitis.
ARUP is using Deep Bio’s artificial intelligence-based software in research to evaluate how use of the software may aid in detection and classification of prostate cancer cells, such as the cells pictured here.
Deep Bio, a leading company in artificial intelligence (AI) cancer diagnostics, announced it obtained an approval from the University of IRB for a real-world implementation study.
Managing the challenge of a global healthcare crisis such as the COVID-19 pandemic requires collaboration, clear and abundant communication, and planning to allow a healthcare system to adapt.
Zachary Wilkey (center), Operations Engineering group manager, explains features of ARUP’s laboratory automation system to members of the Association of University Research Parks (AURP) during a tour that was part of AURP’s annual convention in Salt Lake City.
About 200 research park and innovation district leaders from around the globe visited ARUP to hear how Research Park’s largest tenant has become a model for startups born in research institutions.
ARUP Consult, a free online test selection and interpretation tool, added updated information in September that includes preoperative testing guidance for ovarian cancer biomarkers and testing strategies for malaria.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.